InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Mccormick Frank. Officer active across 1 company, notably BridgeBio Pharma, Inc.. Cumulatively, 10 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €14m. History available since 26 December 2023. The latest transaction was filed on 29 October 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
MCCORMICK FRANK is a Director at BridgeBio Pharma, Inc. The declarant has 10 filings in total, and across the 10 sampled filings the transactions are sales, with EUR 0 of buys and EUR 13,993,769 of sells between 2023-12-28 and 2026-06-24.